Literature DB >> 21810920

Efficient production of antibodies against a mammalian integral membrane protein by phage display.

Isidro Hötzel1, Vicki Chiang, Jingyu Diao, Homer Pantua, Henry R Maun, Sharookh B Kapadia.   

Abstract

The application of phage display technology to mammalian proteins with multiple transmembrane regions has had limited success due to the difficulty in generating these proteins in sufficient amounts and purity. We report here a method that can be easily and generally applied to sorting of phage display libraries with multispan protein targets solubilized in detergent. A key feature of this approach is the production of biotinylated multispan proteins in virions of a baculovirus vector that allows library panning without prior purification of the target protein. We obtained Fab fragments from a naïve synthetic antibody phage library that, when engineered into full-length immunoglobulin (Ig)G, specifically bind cells expressing claudin-1, a protein with four transmembrane regions that is used as an entry co-receptor by the hepatitis C virus (HCV). Affinity-matured variants of one of these antibodies efficiently inhibited HCV infection. The use of baculovirus particles as a source of mammalian multispan protein facilitates the application of phage display to this difficult class of proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810920     DOI: 10.1093/protein/gzr039

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  20 in total

1.  A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Authors:  Adam Zuiani; Kevin Chen; Megan C Schwarz; James P White; Vincent C Luca; Daved H Fremont; David Wang; Matthew J Evans; Michael S Diamond
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  An improved and robust DNA immunization method to develop antibodies against extracellular loops of multi-transmembrane proteins.

Authors:  Meredith Hazen; Sunil Bhakta; Rajesh Vij; Steven Randle; Dara Kallop; Vicki Chiang; Isidro Hötzel; Bijay S Jaiswal; Karen E Ervin; Bing Li; Robby M Weimer; Paul Polakis; Richard H Scheller; Jagath R Junutula; Jo-Anne S Hongo
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 3.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

Review 4.  Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates.

Authors:  Miroslav Dostalek; Thomayant Prueksaritanont; Robert F Kelley
Journal:  MAbs       Date:  2017-05-02       Impact factor: 5.857

5.  Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources.

Authors:  Benjamin J Tillotson; Iñigo F de Larrinoa; Colin A Skinner; Derek M Klavas; Eric V Shusta
Journal:  Protein Eng Des Sel       Date:  2012-10-28       Impact factor: 1.650

6.  Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins.

Authors:  Sharon E Hopcraft; Matthew J Evans
Journal:  Hepatology       Date:  2015-05-12       Impact factor: 17.425

7.  Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.

Authors:  Masayoshi Fukasawa; Shotaro Nagase; Yoshitaka Shirasago; Manami Iida; Mayo Yamashita; Kohki Endo; Kiyohito Yagi; Tetsuro Suzuki; Takaji Wakita; Kentaro Hanada; Hiroki Kuniyasu; Masuo Kondoh
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

8.  A strategy for risk mitigation of antibodies with fast clearance.

Authors:  Isidro Hötzel; Frank-Peter Theil; Lisa J Bernstein; Saileta Prabhu; Rong Deng; Leah Quintana; Jeff Lutman; Renuka Sibia; Pamela Chan; Daniela Bumbaca; Paul Fielder; Paul J Carter; Robert F Kelley
Journal:  MAbs       Date:  2012 Nov-Dec       Impact factor: 5.857

9.  Direct expression and validation of phage-selected peptide variants in mammalian cells.

Authors:  Brian D Quinlan; Matthew R Gardner; Vinita R Joshi; Jessica J Chiang; Michael Farzan
Journal:  J Biol Chem       Date:  2013-05-10       Impact factor: 5.157

10.  Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.

Authors:  Jingyu Diao; Homer Pantua; Hai Ngu; Laszlo Komuves; Lauri Diehl; Gabriele Schaefer; Sharookh B Kapadia
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.